Deutsche Bank analyst Steve Powers lowered the firm’s price target on Kenvue (KVUE) to $22 from $23 and keeps a Hold rating on the shares ...

The stock's rise snapped a five-day losing streak.

In a report released yesterday, Nik Modi from RBC Capital maintained a Hold rating on Kenvue, Inc. (KVUE – Research Report), with a price ...

Public comments open before a final order is issued. Vandana Singh Listerine And Tylenol Maker Kenvue's Q3 Earnings: Revenue Miss On Weak Skin Health And Beauty Sales Kenvue reports Q3 sales of $3 ...

In a filing with the Securities and Exchange Commission, Starboard complimented the Kenvue franchise, but expressed disappointment with management and share-price performance. "Despite the company ...

Kenvue (NYSE:KVUE – Get Free Report) had its target price lowered by equities researchers at UBS Group from $24.00 to $23.00 in a note issued to investors on Thursday,Benzinga reports.

The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Capture valuable insights into Kenvue's market standing by understanding these ...

Kenvue (NYSE:KVUE – Get Free Report) had its price target decreased by equities researchers at Citigroup from $25.00 to $21.00 in a report released on Wednesday,Benzinga reports. The firm curren ...

Starboard disclosed in October that the fund accumulated a stake and was pushing for changes to help the company's stock price. Kenvue needs to focus on fixing its skin, health and beauty segments ...

These ratings communicate expectations for the relative performance of Kenvue compared to the broader market. Price Targets: Analysts gauge the dynamics of price targets, providing estimates for ...